Brands
-
Aimil Pharmaceuticals India Ltd
Today AIMIL is known as one of the leading health contributors to the society by Innovations Developments- Manufacturing- Marketing and Promoting a wide range of Ayurveda products of therapeutic grade in different dosage form benefiting in several acute- sub-acute and chronic disease conditions. AIMIL always endeavored to bring revolutionary innovations in developing and conceiving the concept of medication with technologies and manufacturing them in GMP certified, utmost precious and automated units, that validates international quality specifications including ISO 9001:2008. Growing at a rapid pace, AIMIL has a strong team of more than 2000 manpower reaching turnover of value INR 400 Crores in FY 2020-2021. and have an eminent presence in India and in many parts across the globe.
-
Galderma is the pure-play dermatology category leader, committed to advancing dermatology for every skin story. Leveraging our unique 40-year heritage of leading science-based innovation, we deliver a synergistic portfolio of flagship brands and services that span the full spectrum of dermatology.
-
Mankind Pharma initially targeted price-sensitive drugs, with a focus on rural market; its early products included antibacterial drug Zenflox and prescription antibiotic Moxikind CV, which were priced at a steep discount to the existing products in the market. The company ventured into the over-the-counter segment in 2007, focusing primarily on sexual healthcare products.
-
About Micro Labs
We are a technology-focused, multi-dimensional pharmaceutical company having state-of-the-art manufacturing capabilities in diverse therapeutic areas such as Cardiology, Diabetology, Pain Management, Dermatology, Ophthalmology, Neurology and more. We strive towards unlocking the power of science to provide access to affordable and innovative medicines to improve health outcomes and make a difference in people's lives across the globe.
As we continue to champion the cause of Make-in-India through our steady expansion across various Indian states, we create job opportunities and drive social responsibility programs in education, healthcare, rural development and environmental protection to add value to our local communities. Our roadmap is to continue investing in discovering, developing, manufacturing, and commercializing innovative medicines. Meeting the growth and profitability goals through successful innovation in digital healthcare trends and commercial excellence will continue to be the driving factors over the next decade.
-
Pfizer Limited has a state-of-the-art local market supply facility in Goa that manufactures over 4 billion oral contraceptives, steroid tablets and general tablets annually. (That’s 10 million tablets every single day, or more than 7500 tablets every minute!)
All manufacturing operations are carried out in full compliance with local laws and in line with stringent Global Pfizer Quality and environment, health and safety (EHS) standards.
-
On a journey to make the Indian lifestyle healthy, full of energy, and sound-minded. We help tackle fast-paced life & achieve overall well-being by providing our retailers with a delightful margin yet keeping it light on the pocket of our consumers.
-
Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited), a leading Indian Pharmaceutical company is a fully integrated, global healthcare provider. With in-depth domain expertise in the field of healthcare, it has strong capabilities across the spectrum of the pharmaceutical value chain. From formulations to active pharmaceutical ingredients and animal healthcare products to wellness products, Zydus has earned a reputation amongst Indian pharmaceutical companies for providing comprehensive and complete healthcare solutions.
One of the salient features of Zydus is its rich history and lineage. The origin of the company dates all the way back to the 1950s. The company was founded in the year 1952 by Mr. Ramanbhai B. Patel (late), a first-generation entrepreneur and a doyen in the field of Indian Pharmaceuticals.
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 17,000 crores in FY-21.
Adhering to its brand promise of being dedicated to life in all its dimensions, Zydus continues to innovate with an unswerving focus to address the unmet healthcare needs. Simultaneously it rededicates itself to its mission of creating healthier, happier communities across the globe.